Massachusetts Financial Services CO Senseonics Holdings, Inc. Transaction History

Massachusetts Financial Services CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$0.97 - $1.94 $987,016 - $1.97 Million	-1,017,543 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.81 - $2.45 $3.15 Million - $4.27 Million	-1,741,109 Reduced 63.11%	1,017,543 $2.08 Million
Q1 2019 May 13, 2019	SELL	$2.3 - $3.27 $2.16 Million - $3.07 Million	-937,881 Reduced 25.37%	2,758,652 $6.76 Million
Q4 2018 Feb 08, 2019	BUY	$2.49 - $4.54 $1.53 Million - $2.79 Million	613,995 Added 19.92%	3,696,533 $9.57 Million
Q3 2018 Oct 25, 2018	BUY	$3.4 - $4.84 $10.5 Million - $14.9 Million	3,082,538 New	3,082,538 $14.7 Million

138

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $396M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.